Volume 32, Issue 2 pp. 145-147

Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis

P. D. Arkwright

P. D. Arkwright

Academic Unit of Child Health, University of Manchester, Booth Hall Children's Hospital, Charlestown Road, Manchester, UK

Search for more papers by this author
M. C. Gillespie

M. C. Gillespie

Academic Unit of Child Health, University of Manchester, Booth Hall Children's Hospital, Charlestown Road, Manchester, UK

Search for more papers by this author
C. I. Ewing

C. I. Ewing

Academic Unit of Child Health, University of Manchester, Booth Hall Children's Hospital, Charlestown Road, Manchester, UK

Search for more papers by this author
T. J. David

T. J. David

Academic Unit of Child Health, University of Manchester, Booth Hall Children's Hospital, Charlestown Road, Manchester, UK

Search for more papers by this author
First published: 14 December 2006
Citations: 10
Dr Peter Arkwright, FRCPCH, DPhil, Booth Hall Children's Hospital, Charlestown Road., Manchester M9 7AA, UK.
E-mail: [email protected]

Conflict of interest: there are no conflicts of interest.

Summary

There is little information on the relative efficacy of topical tacrolimus and corticosteroids in the treatment of atopic dermatitis (AD) in children. In a single-centre, prospective, observer-blinded, side-to-side comparative study (ISRCTN65507338), 96 children with moderately severe AD were enrolled. The study aimed to compare the relative effectiveness of the child's usual topical corticosteroid with 0.03% tacrolimus ointment applied for 1 week, and if there was no difference, 0.1% tacrolimus ointment applied for a further week. Topical tacrolimus was found to be more effective than topical corticosteroid in 72 of the 93 children (77%) who completed the study. Using multiple-regression analysis with age, gender, pretreatment surface area affected and pretreatment corticosteroid potency as covariants, the only factor that reduced the chance of observing a beneficial effect with tacrolimus was moderate or potent topical corticosteroid use (OR = 0.13; 95% CI 0.02–0.74).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.